LCM
TERN

Landscape Capital Management’s Terns Pharmaceuticals TERN Stock Holding History

Landscape Capital Management’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$224K Buy
+4,248
New +$174K 0.01% 620
2025
Q4 		– Sell
-13,196
Closed -$99.1K – 894
2025
Q3 		$99.1K Hold
13,196
– – 0.01% 582
2025
Q2 		$49.2K Hold
13,196
– – ﹤0.01% 622
2025
Q1 		$36.4K Hold
13,196
– – ﹤0.01% 598
2024
Q4 		$73.1K Buy
+13,196
New +$89.4K 0.01% 678

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Landscape Capital Management's TERN Position: Q1 2026 in Review

Landscape Capital Management opened a new position in Terns Pharmaceuticals (TERN) in Q1 2026: 4,248 shares worth $224K. The stake represents 0.01% of the portfolio and ranks #620 among its holdings. This is a return to the name: Landscape Capital Management previously reported a position in TERN as recently as Q3 2025.

Landscape Capital Management first reported a position in TERN in Q4 2024 and has held it in 5 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Landscape Capital Management held 4,248 shares of Terns Pharmaceuticals worth $224K as of Q1 2026.
  • Terns Pharmaceuticals was a new Landscape Capital Management position in Q1 2026.
  • Terns Pharmaceuticals made up 0.01% of Landscape Capital Management's portfolio in Q1 2026, its #620 holding.
  • Landscape Capital Management first reported a position in Terns Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Landscape Capital Management's 13F filing for Q1 2026, filed 12 May 2026.